Repligen | RGEN - Ordinary Share Capital

Stock Price
117.60
Daily Change
3.54 3.10%
Monthly
2.87%
Yearly
-18.76%
Q2 Forecast
115.08

Repligen reported $56.32M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agilent USD 282.7M 358K Dec/2025
Align Technology USD 71.75M 736K Dec/2025
Bio Techne USD 155.75M 154.18M Sep/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Bruker USD 151.94M 225K Dec/2025
Charles River Laboratories USD 49.22M 2K Dec/2025
Danaher USD 707.7M 800K Mar/2026
Dentsply International USD 199.5M 196.5M Sep/2025
General Electric Aerospace USD 1.04B 5.43M Mar/2026
Henry Schein USD 115.77M 2.8M Dec/2025
Illumina USD 152.8M 900K Dec/2025
IQVIA Holdings USD 169.6M 700K Dec/2025
Mettler Toledo International USD 20.43M 170.6K Dec/2025
Myriad Genetics USD 93.5M 400K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Repligen USD 56.32M 42K Dec/2025
Revvity USD 113.38M 2.7M Dec/2025
Standard Biotools USD 386.38M 2.77M Dec/2025
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Waters USD 98.08M 38.55M Dec/2025
West Pharmaceutical Services USD 70.9M 1.1M Mar/2026